Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients - Sun, Yidan; Zhang, Ying; Ren, Shiqi; Li, Xiaojiang; Yang, Peiying; Zhu, Jinli; Lin, Lisen; Wang, Ziheng; Jia, Yingjie (International immunopharmacology, 2020)
Keywords: Adenocarcinoma; Adenocarcinoma - diagnosis; Adenocarcinoma - metabolism; Adenocarcinoma - mortality; B-Lymphocytes - immunology; Bioinformatics; Biomarkers; Cancer; CD8 antigen; CD8-Positive T-Lymphocytes - immunology; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Genomes; Gluconeogenesis; Glycolysis; Health risks; Humans; Immune checkpoint; Immune infiltrate; Immune system; Immunological memory; Immunotherapy; Infiltration; Leukocytes (neutrophilic); Lung - immunology; Lung Adenocarcinoma; Lung Neoplasms - diagnosis; Lung Neoplasms - metabolism; Lung Neoplasms - mortality; Lungs; Lymphocytes; Lymphocytes B; Lymphocytes T; Male; Medical prognosis; Memory cells; Metastases; Middle Aged; Morbidity; p53 Protein; Prognosis; ral Guanine Nucleotide Exchange Factor - genetics; ral Guanine Nucleotide Exchange Factor - metabolism; RGL4; Ribonucleic acid; RNA; Signal Transduction; Signaling; Survival Analysis; TCGA; Tumor Suppressor Protein p53 - metabolism; Tumor-infiltrating lymphocytes; Biomarkers; Lung Adenocarcinoma; Immune infiltrate; RGL4; Bioinformatics; TCGA